Search Results
Viewing: 7721-7730 of 12447 | All
Resources & Educational Opportunities
Suicide affects people of all backgrounds. Although the prevalence of mental health disorders and rates of suicide increase as children grow older, even young children express thoughts of suicide and have died by suicide. However, there is hope.
Our People
Our research faculty is dedicated to discovering new methods of diagnosing, treating and preventing diseases in kids everywhere.
Article
Jerry R. Mendell
Jerry R. Mendell, MD, is an advisor to the Jerry R. Mendell Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s and to Sarepta Therapeutics. He is also an emeritus professor of Pediatrics at The Ohio State University.
Pediatric Colorectal Research Fellowship
The Pediatric Colorectal Research Fellowship is a one or two-year program. The fellow will research the treatment and long-term outcomes of patients with pediatric colorectal problems and may also possess surgical assistant responsibilities.
Pediatric Colorectal Fellowship
The Pediatric Colorectal Fellowship is a one-year program, or a two-year program with additional research that provides training in advanced colorectal surgery and collaborating specialties, including GI motility and pelvic reconstruction.
Article
Breuer Lab Staff
Christopher Breuer, MD Director Christopher.Breuer@NationwideChildrens.org Dr. Breuer is Co-Director of the new Tissue Engineering Program at Nationwide Children's Hospital and Director of Tissue Engineering in The Ohio State University Wexner Medical Center's new Center for Regenerative Medicine
Article
Breuer Lab
The focus of the Breuer and Shinoka Labs is to design a tissue engineered vascular graft (TEVG) that can be used during surgery that, over time transitions to a normal blood vessel that will grow with our pediatric patients.
Specialty
Center for Childhood Cancer Research
The Center for Childhood Cancer Research focuses on expanding the understanding of the pathogenesis of childhood cancer and to improving strategies for diagnosis and treatment.
Article
FDA Approval
The FDA has issued an accelerated approval for a second gene therapy developed at Nationwide Children's Hospital, bringing hope to children with Duchenne muscular dystrophy.